With government debt soaring and inflation still biting, smart investors aren't waiting for volatility to hit — they're preparing now. The Gold Wealth Blueprint breaks down exactly how gold has historically shielded portfolios during periods of fiscal strain and market uncertainty.
Inside, you'll discover why gold moves differently than paper assets, how to use it as a practical hedge, and how to size your exposure without overcommitting. It's concise, actionable, and free — but don't sit on it.
Get the Free Gold Wealth BlueprintBy following the link above, you're choosing to opt in to receive insightful updates from Investor News + 2 free bonus subscriptions. Your privacy is important to us. You can unsubscribe anytime. See our privacy policy for details.
Live Well. Invest Smart. No Apologies.
Image via Fox Business
GLP-1 Drugs Just Torched a Third of Bariatric Surgery Revenue
A new industry report shows GLP-1 weight loss drugs drove a 34.1% drop in bariatric surgery volumes as semaglutide and its cousins reshape how hospitals generate revenue. We're watching an entire surgical subspecialty get disrupted in real time, and the implications run far beyond the OR.
Hospital systems built revenue models around high-margin procedures like gastric bypass and sleeve gastrectomy. Those procedures are expensive, repeatable, and came with long recovery protocols that meant more billable care. Now patients are getting results with a weekly injection, and the math for health systems is starting to look ugly. Meanwhile, Novo Nordisk and Eli Lilly are printing money.
This isn't just about hospitals scrambling to backfill lost surgery revenue. It's about supply chains, medical device manufacturers, anesthesiology groups, and the entire ecosystem that fed off obesity treatment. If you're holding hospital REITs or med-device stocks heavily weighted toward bariatric equipment, you're holding yesterday's trade.
🥃 Cole's Take: I've seen technological disruption kill entire business models before, but rarely this fast. If you're long traditional healthcare infrastructure without a plan for how GLP-1s rewrite utilization, you're not paying attention. The winners here are the drug makers and whoever figures out the next-gen delivery and logistics play.
Image via MarketWatch
Treasury's Buyback Plan Might Backfire Exactly How JPMorgan Warns
JPMorgan strategists Jay Barry and Jason Hunter are sounding alarms about the Treasury's bond buyback program, predicting it could drive yields higher rather than stabilizing the market. Their view: the move wasn't even necessary, and the fallout could catch investors off guard.
The Treasury is trying to smooth out liquidity and manage the maturity wall, but JPMorgan sees it creating unintended distortions. When the government starts buying back its own paper in size, it can tighten spreads in the wrong places and push capital into positions that don't reflect actual risk. The strategists are advising clients to stay defensive and watch the short end closely.
This comes at a time when the deficit isn't shrinking and the Fed's still navigating a tricky landing. If Treasury buybacks end up juicing yields, the cost of borrowing goes up for everyone—corporations, homebuyers, and the government itself. It's a policy feedback loop that could get expensive fast.
🥃 Cole's Take: When JPMorgan says a Treasury move is unnecessary and risky, I listen. This smells like intervention for intervention's sake, and the bond market has a way of punishing that. If you're overweight duration, now's the time to reassess your exposure before this thing bites.
Image via The Street
Vanguard Just Warned Your 401(k) About Private Equity's Math Problem
Vanguard is raising red flags about the push to load private equity into 401(k) plans, calling out what they see as a $3.8 trillion problem headed straight for retirement accounts. Wall Street's been pitching PE as the secret sauce for retiree returns, but Vanguard's math tells a different story.
The pitch sounds great: illiquid assets, premium returns, diversification away from public markets. The reality is murkier. PE comes with high fees, long lockups, and valuations that aren't marked to market daily—which means your statement might look fine right up until it doesn't. For retirees who need liquidity and transparency, that's a dangerous combo.
This isn't about PE being a bad asset class. It's about suitability. Institutional investors can handle a 10-year lockup and survive a down mark. A 62-year-old trying to retire can't. Vanguard's calling out the structural mismatch, and they're right to do it before this becomes the next misselling scandal.
🥃 Cole's Take: I've allocated to private equity in the right context, but jamming it into 401(k)s for mass market retirees is a recipe for disaster. The fee drag alone will eat returns, and when liquidity dries up in the next downturn, it'll be ugly. This is Wall Street trying to access retail capital, not help it.
Image via Robb Report
Toyota's New GR GT Is Already Gone—And That's the Whole Point
Toyota's new GR GT hasn't even hit showrooms, and the initial U.S. allocation is already spoken for. If you didn't get your name on a list months ago, you're out of luck. And Toyota planned it exactly that way.
This is scarcity as strategy. In a world where most automakers are chasing volume and trying to flood dealer lots, Toyota is taking the opposite bet with its halo performance models. Limited runs, dealer allocations locked down early, and a customer base that's willing to pay over sticker just for access. It's the same playbook that's worked for Porsche GT cars and Ford's limited-run Mustangs.
The GR GT isn't about moving units. It's about brand elevation and creating desire. Toyota knows that if you make something hard to get, people will want it more—and they'll pay more when they finally get a shot. In a market flooded with inventory and incentives, exclusivity still sells.
🥃 Cole's Take: I respect the discipline here. Toyota could easily flood the market and move metal, but instead they're building a brand halo that'll lift the entire GR lineup. Scarcity creates value, and in a commoditized market, that's how you win the premium game.
New England's Best Food Town Isn't Where You Think It Is
Travel + Leisure just named America's best small food town, and it's not Napa, not Charleston, not Portland. It's a New England coastal spot loaded with James Beard-nominated restaurants, a maritime museum, and some of the region's best seafood. The kind of place where you can still find authenticity before it gets Instagrammed into oblivion.
What makes a food town worth the trip isn't Michelin stars or celebrity chefs—it's the combination of local ingredients, generational knowledge, and a culture that actually cares about what's on the plate. This town checks those boxes. Fresh-off-the-boat seafood, chefs who know the fishermen by name, and restaurants that aren't trying to be anything other than excellent at what they do.
It's also the kind of place that reminds you why you work hard. A long weekend, great meals, good whisky, and water views that don't require a resort fee. Sometimes the best travel isn't about the biggest destination—it's about the places that still feel real.
🥃 Cole's Take: I'll take a small coastal town with honest food and no scene over another overpriced resort destination any day. These are the spots worth seeking out before the crowds show up and ruin the vibe. Book it now while it's still a hidden gem.
Image via Golf.com
Rory McIlroy Says There's No Such Thing as Too Much Money in Golf
Rory McIlroy, speaking at his 2026 BMW Championship press conference, shot down critics who think there's too much money in professional golf. His take: if someone is willing to pay, the market is working exactly as it should.
He's not wrong. The PGA Tour, LIV, and the entire professional golf ecosystem have been reshaped by capital that saw an undervalued asset and decided to compete for it. Players are getting paid what the market will bear, and the hand-wringing about prize money is mostly coming from people who don't understand how markets work. If the money wasn't there, the players wouldn't be getting it.
The broader point is about talent valuation and scarcity. There are only so many players who can compete at the highest level, and when deep-pocketed backers decide to compete for that talent, prices go up. It's the same dynamic that drives executive comp, pro sports contracts, and every other market where elite performance is scarce.
🥃 Cole's Take: Rory's right, and the people clutching pearls about player salaries don't get it. This is capitalism working. If you don't like it, don't watch—but the market has spoken, and the players are finally getting paid what they're worth. No apologies needed.
📎 Golf.com
Live well. Stay sharp. And remember—scarcity still beats access every time. — Cole
— Cole Hargrove